Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (411-420 of 999) with videos related to

Pageof 100
Sort By:
Journal of Clinical Lipidology|November 24, 2011
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)Jennifer G Robinson, Christie M Ballantyne, Willa Hsueh, et al.
JACC. Heart Failure|December 3, 2014
Obesity, subclinical myocardial injury, and incident heart failureChiadi E Ndumele, Josef Coresh, Mariana Lazo, et al.
The American Journal of Medicine|March 31, 2020
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018Mahmoud Al Rifai, Anwar T Merchant, Vijay Nambi, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 1993
Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in miceS E Welty, J L Rivera, J F Elliston, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Eotaxin and obesityAbu R Vasudevan, Huaizhu Wu, Antonios M Xydakis, et al.
Stroke|March 9, 2013
Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities studyAaron R Folsom, Vijay Nambi, Elizabeth J Bell, et al.
Journal of Clinical Lipidology|May 22, 2016
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studiesChristie M Ballantyne, Harold E Bays, Rene A Braeckman, et al.
Atherosclerosis|April 17, 2017
Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trialStephen J Nicholls, Kausik K Ray, Christie M Ballantyne, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 31, 2014
Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities studyKunihiro Matsushita, Yingying Sang, Shoshana H Ballew, et al.
Journal of General Internal Medicine|October 6, 2023
Implementation and Evaluation of a mHealth-Based Community Health Worker Feedback Loop for Hispanics with and at Risk for DiabetesElizabeth M Vaughan, Victor J Cardenas, Wenyaw Chan, et al.
Pageof 100

Showing results (411-420 of 999) with videos related to

Sort By:
Pageof 100
Journal of Clinical Lipidology|November 24, 2011
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)Jennifer G Robinson, Christie M Ballantyne, Willa Hsueh, et al.
JACC. Heart Failure|December 3, 2014
Obesity, subclinical myocardial injury, and incident heart failureChiadi E Ndumele, Josef Coresh, Mariana Lazo, et al.
The American Journal of Medicine|March 31, 2020
Temporal Trends in E-Cigarette Use Among U.S. Adults: Behavioral Risk Factor Surveillance System, 2016 to 2018Mahmoud Al Rifai, Anwar T Merchant, Vijay Nambi, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 1993
Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in miceS E Welty, J L Rivera, J F Elliston, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Eotaxin and obesityAbu R Vasudevan, Huaizhu Wu, Antonios M Xydakis, et al.
Stroke|March 9, 2013
Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities studyAaron R Folsom, Vijay Nambi, Elizabeth J Bell, et al.
Journal of Clinical Lipidology|May 22, 2016
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studiesChristie M Ballantyne, Harold E Bays, Rene A Braeckman, et al.
Atherosclerosis|April 17, 2017
Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trialStephen J Nicholls, Kausik K Ray, Christie M Ballantyne, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 31, 2014
Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities studyKunihiro Matsushita, Yingying Sang, Shoshana H Ballew, et al.
Journal of General Internal Medicine|October 6, 2023
Implementation and Evaluation of a mHealth-Based Community Health Worker Feedback Loop for Hispanics with and at Risk for DiabetesElizabeth M Vaughan, Victor J Cardenas, Wenyaw Chan, et al.
Pageof 100